Core Points - 康臣药业 has been actively repurchasing its shares, with a total of 28,000 shares bought back on October 30 at prices ranging from 14.960 to 15.080 HKD, amounting to 4.2053 million HKD [1] - The stock has seen a decline of 5.94% since the start of the recent repurchase program on October 14, during which the company has repurchased a total of 2.65 million shares for 40.4171 million HKD [1] - Year-to-date, 康臣药业 has conducted 30 repurchase transactions, totaling 7.845 million shares and 98.9482 million HKD in repurchase amounts [1] Repurchase Details - On October 30, 康臣药业 repurchased 28,000 shares at a maximum price of 15.080 HKD and a minimum price of 14.960 HKD, totaling 4.2053 million HKD [2] - The company has consistently repurchased shares over the past 12 days, with the most significant repurchase occurring on October 23, where 42,200 shares were bought back at an average price of 15.040 HKD [1][2] - The cumulative repurchase activity reflects a strategic effort to stabilize the stock price amid a downward trend, as evidenced by the stock's closing price of 15.050 HKD on October 30, down 2.46% for the day [1]
康臣药业(01681.HK)连续12日回购，累计斥资4041.71万港元